Golgi apparatus-targeted BODIPY-based photosensitizer synergized with glutaminase inhibition for enhanced photodynamic therapy
Authors:
- Jiawei LiJLJiawei Li
- Qiqi YuQYQiqi Yu
- Yang LiYLYang Li
- Dongdong XuDXDongdong Xu
- Shouchun YinSYShouchun Yin
- 10 July 2024
- journal article
- research article
- Published by Elsevier in Dyes and Pigments
- Vol. 230
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- BODIPY as a Multifunctional Theranostic Reagent in Biomedicine: Self‐Assembly, Properties, and ApplicationsAdvanced Materials, 2023
- The tumor EPR effect for cancer drug delivery: Current status, limitations, and alternativesAdvanced Drug Delivery Reviews, 2022
- Potential role of mitochondria-associated endoplasmic reticulum membrane proteins in diseasesBiochemical Pharmacology, 2022
- Enzymatic Assemblies of Thiophosphopeptides Instantly Target Golgi Apparatus and Selectively Kill Cancer Cells**Angewandte Chemie International Edition, 2021
- Cancer‐Cell‐Activated in situ Synthesis of Mitochondria‐Targeting AIE Photosensitizer for Precise Photodynamic TherapyAngewandte Chemie International Edition, 2021
- Mitochondria‐Specific Agents for Photodynamic Cancer Therapy: A Key Determinant to Boost the EfficacyAdvanced Healthcare Materials, 2020
- Photosensitizers with Aggregation‐Induced Emission: Materials and Biomedical ApplicationsAdvanced Materials, 2018
- The potential of Pluronic polymeric micelles encapsulated with paclitaxel for the treatment of melanoma using subcutaneous and pulmonary metastatic mice modelsBiomaterials, 2011
- New Insights into the Role of Mitochondria-Associated Endoplasmic Reticulum Membrane2011
- Targeting of proteins to the Golgi apparatusHistochemistry and Cell Biology, 1998